TY  - JOUR
T1  - PErcutaneous intervention for non–st-segment elevation myocardial infarction within the therapeutic time window for acute myocardial infarction
AU  - Jolobe OP
Y1  - 2011/05/23
N1  - 10.1001/archinternmed.2011.191
JO  - Archives of Internal Medicine
SP  - 941
EP  - 954
VL  - 171
IS  - 10
N2  - 
Even allowing for some ambiguity in the wording of that statement, the role of percutaneous intervention (PCI) in patients with non-STEMI who have angiographic documentation of thrombotic occlusion within the 3-hour therapeutic time window, which is the one advocated for PCI treatment of acute myocardial infarction,3 can only be established by a randomized controlled trial. For such a trial to enroll sufficient numbers of patients, obstacles to early presentation2 will have to be eliminated, including the delay between arrival in hospital and team notification.1 Furthermore, when interpreting the results of such a trial, allowance will also have to be made for the fact that 60% to 65.5% of patients with non-STEMI have multivessel coronary artery disease,1,4 and that

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2011.191
UR  - http://dx.doi.org/10.1001/archinternmed.2011.191
ER  -